Evista is used to reduce the risk of hormone-receptor-positive breast cancer in postmenopausal women who haven't been diagnosed but are at higher-than-average risk for disease. It also used to reduce the risk of hormone-receptor-positive breast cancer in postmenopausal women being treated for osteoporosis who haven't been diagnosed with breast cancer. Treat and prevent osteoporosis in postmenopausal women.
Visit : http://www.daynighthealthcare.co/ProductDetails.aspx?pkid=13&catId=2